Catalys by Optimedica
The CATALYS™ Precision Laser System was developed by OptiMedica® Corp. (Sunnyvale, Calif., USA) in close collaboration with a Medical Advisory Board of cataract experts from around the world. CATALYS™ was CE mark approved in August 2011 and market cleared by the U.S. Food and Drug Administration in December 2011.
OptiMedica® Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Exclusively focused in the cataract therapeutic area, the company has developed the CATALYS™ Precision Laser System to deliver unparalleled precision in cataract surgery. For more information, please visit www.optimedica.com.